A detailed history of Distillate Capital Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Distillate Capital Partners LLC holds 240,856 shares of AMGN stock, worth $63.4 Million. This represents 3.93% of its overall portfolio holdings.

Number of Shares
240,856
Previous 112,034 114.98%
Holding current value
$63.4 Million
Previous $35 Million 121.7%
% of portfolio
3.93%
Previous 1.89%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $39.9 Million - $43.5 Million
128,822 Added 114.98%
240,856 $77.6 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $29.4 Million - $35.8 Million
111,992 Added 266647.62%
112,034 $35 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $11,292 - $13,631
42 New
42 $11.9 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $214 - $253
1 Added 2.33%
44 $9.77 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $10.1 Million - $12.8 Million
-43,962 Reduced 99.9%
43 $11.3 Million
Q3 2022

Nov 09, 2022

SELL
$224.46 - $253.15 $1.07 Million - $1.2 Million
-4,746 Reduced 9.74%
44,005 $10.2 Million
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $1.05 Million - $1.17 Million
4,565 Added 10.33%
48,751 $11.9 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $1.47 Million - $1.63 Million
6,715 Added 17.92%
44,186 $10.7 Million
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $2.82 Million - $3.23 Million
14,177 Added 60.86%
37,471 $8.43 Million
Q3 2021

Nov 05, 2021

BUY
$212.27 - $248.7 $979,201 - $1.15 Million
4,613 Added 24.69%
23,294 $4.95 Million
Q2 2021

Jul 30, 2021

SELL
$233.58 - $259.14 $107,680 - $119,463
-461 Reduced 2.41%
18,681 $4.55 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $1.74 Million - $2.03 Million
7,862 Added 69.7%
19,142 $4.76 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $2.44 Million - $2.91 Million
11,280 New
11,280 $2.56 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Distillate Capital Partners LLC Portfolio

Follow Distillate Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Distillate Capital Partners LLC with notifications on news.